Advertisement
Screener

BIOVENTUS INC. (BVS) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

2.8 / 5 stars · 68/120 Roast Me

BIOVENTUS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-27 was 25.00K shares, a 80.00% decline year-over-year.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-28 was 30.00K shares, a 11.76% decline year-over-year.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 8.00K shares, a 86.89% decline year-over-year.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-27 was 52.00K shares, a 60.61% decline year-over-year.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 219.00K shares, a 48.10% decline from fiscal 2024.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 422.00K shares, a 529.85% increase from fiscal 2023.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 67.00K shares, a 90.15% decline from fiscal 2022.
  • BIOVENTUS INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 680.00K shares, a 818.92% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2026-06-2725.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
115.00K shares
derived: sum of 4 quarters · filed 2026-08-05
2026-03-2830.00K shares
10-Q · filed 2026-05-06
215.00K shares
derived: sum of 4 quarters · filed 2026-05-06
2025-12-318.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
219.00K shares
10-K · filed 2026-03-05
2025-09-2752.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
272.00K shares
derived: sum of 4 quarters · filed 2026-03-05
2025-06-28125.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
352.00K shares
derived: sum of 4 quarters · filed 2026-03-05
2025-03-2934.00K shares
10-Q · filed 2025-05-06
247.00K shares
derived: sum of 4 quarters · filed 2026-03-05
2024-12-3161.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
422.00K shares
10-K · filed 2026-03-05
2024-09-28132.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
363.00K shares
derived: sum of 4 quarters · filed 2025-03-11
2024-06-2920.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
2024-03-30209.00K shares
10-Q · filed 2024-05-07
2023-12-312.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
67.00K shares
10-K · filed 2025-03-11
2022-12-31168.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12
680.00K shares
10-K · filed 2024-03-12
2022-10-0141.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21
2022-07-02244.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
2022-04-02227.00K shares
10-Q · filed 2022-05-11
2021-12-3174.00K shares
10-K · filed 2023-03-31